Olli Carpen (Olli Carpén)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 15

Top Topics

Top Venues

Hepatology (Baltimore, Md.)

Science advances

The Journal of pathology

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Iiris Nyholm, Maria Hukkinen, Marjut Pihlajoki, Joseph Rutherford Davidson, Athanasios Tyraskis, Jouko Lohi, Päivi Heikkilä, Satu Hänninen, Noora Andersson, Katja Eloranta, Olli Carpen, Markku Heikinheimo, Mark Davenport, Mikko P Pakarinen
Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia. Hepatology (Baltimore, Md.) 77 (4) (2023)
Iiris Nyholm, Maria Hukkinen, Marjut Pihlajoki, Joseph Rutherford Davidson, Athanasios Tyraskis, Jouko Lohi, Päivi Heikkilä, Satu Hänninen, Noora Andersson, Katja Eloranta, Olli Carpen, Markku Heikinheimo, Mark Davenport, Mikko P Pakarinen
Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia. Hepatology (Baltimore, Md.) (2023)
Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, Jaana Oikkonen, Yilin Li, Fernando Pérez-Villatoro, Taru A Muranen, Matilda Salko, Kaisa Huhtinen, Anna Kanerva, Heidi Koskela, Johanna Tapper, Riitta Koivisto-Korander, Titta Joutsiniemi, Ulla-Maija Haltia, Heini Lassus, Sampsa Hautaniemi, Anniina Farkkila, Johanna Hynninen, Sakari Hietanen, Olli Carpen, Liisa Kauppi
Functional homologous recombination assay on FFPE specimens of advanced high-grade serous ovarian cancer predicts clinical outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Iiris Nyholm, Maria Hukkinen, Marjut Pihlajoki, Joseph Rutherford Davidson, Athanasios Tyraskis, Jouko Lohi, Päivi Heikkilä, Satu Hänninen, Noora Andersson, Katja Eloranta, Olli Carpen, Markku Heikinheimo, Mark Davenport, Mikko P Pakarinen
Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia. Hepatology (Baltimore, Md.) 77 (4) (2023)
Iiris Nyholm, Maria Hukkinen, Marjut Pihlajoki, Joseph Rutherford Davidson, Athanasios Tyraskis, Jouko Lohi, Päivi Heikkilä, Satu Hänninen, Noora Andersson, Katja Eloranta, Olli Carpen, Markku Heikinheimo, Mark Davenport, Mikko P Pakarinen
Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia. Hepatology (Baltimore, Md.) (2023)
Iiris Nyholm, Maria Hukkinen, Marjut Pihlajoki, Joseph Rutherford Davidson, Athanasios Tyraskis, Jouko Lohi, Päivi Heikkilä, Satu Hänninen, Noora Andersson, Katja Eloranta, Olli Carpen, Markku Heikinheimo, Mark Davenport, Mikko P Pakarinen
Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia. Hepatology (Baltimore, Md.) 77 (4) (2023)
Iiris Nyholm, Maria Hukkinen, Marjut Pihlajoki, Joseph Rutherford Davidson, Athanasios Tyraskis, Jouko Lohi, Päivi Heikkilä, Satu Hänninen, Noora Andersson, Katja Eloranta, Olli Carpen, Markku Heikinheimo, Mark Davenport, Mikko P Pakarinen
Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia. Hepatology (Baltimore, Md.) 77 (4) (2023)
Miika Koskinen, Jani K Salmi, Anu Loukola, Mika J Mäkelä, Juha Sinisalo, Olli Carpen, Risto Renkonen
Data-driven comorbidity analysis of 100 common disorders reveals patient subgroups with differing mortality risks and laboratory correlates. Scientific reports 12 (1) (2022)
Kaiyang Zhang, Erdogan Pekcan Erkan, Sanaz Jamalzadeh, Jun Dai, Noora Andersson, Katja Kaipio, Tarja Lamminen, Naziha Mansuri, Kaisa Huhtinen, Olli Carpen, Sakari Hietanen, Jaana Oikkonen, Johanna Hynninen, Anni Virtanen, Antti Häkkinen, Sampsa Hautaniemi, Anna Vaharautio
Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer. Science advances 8 (8) (2022)
Anna N Cvrljevic, Umar Butt, Kaisa Huhtinen, Tove J Grönroos, Camilla Böckelman, Heini Lassus, Ralf Bützow, Caj Haglund, Katja Kaipio, Tiina Arsiola, Teemu Daniel Laajala, Denise C Connolly, Ari Ristimäki, Olli Carpen, Jeroen Pouwels, Jukka Westermarck
Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype. Molecular cancer therapeutics 21 (7) (2022)
Ulla-Maija Haltia, Marjut Pihlajoki, Noora Andersson, Lotta Mäkinen, Johanna Tapper, Alejandra Cervera, Hugo M Horlings, Ursula Turpeinen, Mikko Anttonen, Ralf Bützow, Leila Unkila-Kallio, Olli Carpen, David B Wilson, Markku Heikinheimo, Anniina Färkkilä
Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell Tumors. Journal of the Endocrine Society 4 (4) (2020)
Katja Kaipio, Ping Chen, Pia Roering, Kaisa Huhtinen, Piia Mikkonen, Päivi Östling, Laura Lehtinen, Naziha Mansuri, Taina Korpela, Swapnil Potdar, Johanna Hynninen, Annika Auranen, Seija Grénman, Krister Wennerberg, Sampsa Hautaniemi, Olli Carpen
ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors. The Journal of pathology 250 (2) (2019)
Maija H Peippo, Samu Kurki, Hanna Seppänen, Riitta Lassila, Olli Carpen
CA 19-9 doubling time in pancreatic cancer as a predictor of venous thromboembolism: a hospital database study. Acta oncologica (Stockholm, Sweden) 59 (2) (2019)
Emilia Kozłowska, Anniina Färkkilä, Tuulia Vallius, Olli Carpen, Jukka Kemppainen, Seija Grénman, Rainer Lehtonen, Johanna Hynninen, Sakari Hietanen, Sampsa Hautaniemi
Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer. Cancer research 78 (14) (2018)
Elizabeth V Nguyen, Kaisa Huhtinen, Young Ah Goo, Katja Kaipio, Noora Andersson, Ville Rantanen, Johanna Hynninen, Riitta Lahesmaa, Olli Carpen, David R Goodlett
Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells. Molecular & cellular proteomics : MCP 16 (7) (2017)